Search results
Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?
InvestorPlace· 6 hours agoG1 Therapeutics notes that this trial failed to meet its primary endpoint. The overall survival rate for those taking its drug prior to chemotherapy was...
5 Medical Info Systems Stock to Buy for a Stable Portfolio
Zacks via Yahoo Finance· 6 hours agoHIMS also provides prescription medication on a recurring basis and ongoing care from healthcare...
Alnylam says heart drug succeeds in closely watched study
BioPharma Dive via Yahoo Finance· 10 hours agoPositive results from a Phase 3 trial of vutrisiran in transthyretin amyloidosis cardiomyopathy come...
Mannkind: Study proves inhaled insulin effective for adults with Type-1 diabetes
Hartford Business Journal· 3 hours agoMannKind Corp., a biopharmaceutical company based in Danbury, on Saturday announced positive results...
Boston Scientific secures CE mark for Deep Brain Stimulation software
Medical Device Network via Yahoo Finance· 6 hours agoIt follows after the company’s DBS device received its initial clearance from the European...
Photos show Mark Zuckerberg's style evolution — from hoodies to silver chains
Business Insider via Yahoo News· 3 hours agoZuckerberg is pictured above with Facebook's then-chief operating officer, Sheryl Sandberg, and the...
Thermo-Fisher Scientific Inc. (TMO): Did This Healthcare Stock Exceed Expectations in Q1?
Insider Monkey via Yahoo Finance· 3 hours agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In...
Nestle to sell supplements that tackle ‘Ozempic face’
Daily Telegraph· 5 hours agoSwiss skincare company Galderma in April said it was expecting a boom in demand for fillers as more people start to take obesity treatments but do not want to lose weight ...
Pharma stock jumps after receiving inspection report from USFDA for its manufacturing facility
Investing.com· 13 hours agoThe shares of the company have seen positive movement after Lupin Ltd announced that it had received...
If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 5 hours agoIn February 2023, AbbVie acquired ImmunoGen which added the latter’s antibody-drug conjugate (ADC)...